“Smarter screening” and a better understanding of the breast cancers women of color are more likely to develop are all crucial to helping these patients survive this disease at the same rates as their White counterparts.
Scientists at Case Western Reserve University have used artificial intelligence (AI) to identify new biomarkers for breast cancer that can predict whether the cancer will return after treatment—and which can be identified from routinely acquired tissue biopsy samples of early-stage breast cancer.
Most of us have heard about the BRCA1 and BRCA2 genes...but what about the PALB2 gene, which stands for Partner And Locator of BRCA2?
Every day, people are exposed to a variety of synthetic chemicals through the products they use or the food they eat. For many of these chemicals, the health effects are unknown.
A drug that typically is used to treat high cholesterol may be quite useful in the fight against breast cancer.
The COVID-19 pandemic brought mRNA vaccines into the limelight. But the technology may also prove to be a powerful weapon against hard-to-treat cancers.
Can immunotherapy treat breast cancer? For certain patients, the answer is yes.
New research has revealed that a one-year course of a drug called a PARP inhibitor can help to reduce the risk of breast cancer recurrence, and progression to secondary breast cancer, in people with early breast cancer with a change in the BRCA gene.
Researchers say higher vitamin D levels may help improve a person’s odds of surviving breast cancer.
All people (regardless of their sex assigned at birth) have breast tissue and could potentially get breast cancer, but the risk is much higher in people who were AFAB (assigned female at birth).
- ← Previous
- 1
- 2 (current)
- 3
- 4
- Next →